Send to

Choose Destination
Neurotox Res. 2006 Apr;9(2-3):127-31.

Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F.

Author information

Clinical Neuroscience Department, Neurology Section, Umberto I Hospital, Venice, Italy.


Botulinum neurotoxin (BoNT) serotype A is commonly used in the treatment of focal dystonia, but some patients are primarily or become secondarily resistant to it. Consequently, other serotypes have to be used when immuno-resistance is proven. In the literature, patients with focal dystonia have been treated with BoNT serotype F with clinical benefit but with short lasting effects. Recently, BoNT serotype C has been used with positive clinical outcome. An update on the clinical use of BoNT serotype F and BoNT serotype C is provided.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center